The Pharmaceutical Journal
Vol 273 No 7317 p374
18 September 2004

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Restless legs syndrome

Ropinirole (Requip) helps people with restless legs syndrome, according to data presented at the European Federation of Neurological Societies meeting last week. Researchers reviewed four studies involving 818 patients and concluded that ropinirole improved symptoms. An application for a licence has been made.